Ancient-modern concordance in ayurvedic plants: Some examples

Environmental Health Perspectives

Volumn 107, Issue 10, 1999, Pages 783-789

  Dev, Sukh ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Antihyperlipoproteinemic drug; Asparagus racemosus; Ayurveda; Bakuchiol; Cedrus deodara; Commiphora wightti; GABA; Guggulsterones; Himachalol; Psoralea corylifolia; Rauwolfia serpentina; Reserpine; aminobutyric acid

Indexed keywords

ALKALOID; NATURAL PRODUCT;

DIET; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; HEALTH CARE; HYPERTENSION; INDIA; INSOMNIA; MEDICINAL PLANT; MENTAL DISEASE; PHILOSOPHY; PLANT; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE;

ASPARAGUS; ASPARAGUS RACEMOSUS; CEDRUS DEODARA; COMMIPHORA; COMMIPHORA WIGHTII; CULLEN CORYLIFOLIA; PSORALEA; PSORALEA CORYLIFOLIA; RAUVOLFIA SERPENTINA; RAUWOLFIA SERPENTINA;

EID: 0032741242     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.99107783     Document Type: Review

References (127)

1. The British Pharmacopoeia. London:General Medical Council, 1932.
2. British Pharmacopoeia. London:Her Majesty's Stationery Office, 1980.
3. Dev S. Ethnotherapeutics and modern drug development the potential of Ayurveda. Curr Sci 73:909-928 (1997).
4. Beecher CWW, Farnsworth NR, Gyllenhaal C. Pharmacologically active secondary metabolites from wood. In: Natural Products of Woody Plants, Vol II (Rowe JW, ed). Berlin:Springer-Verlag, 1989;1059-1164.
5. Bisset NG, ed. Herbal Drugs and Phytopharmaceuticals. Boca Raton, FL:CRC Press, 1994.
6. Rawls R. Europe's strong herbal brew. Chem Eng News 74(39):53-60 (1996).
7. Kinghorn AD, Seo E-K. Cultivating the pharmacopoeia. Chemtech 26:46-54 (July 1998).
8. Tyler VE. The herbal remedies market. Chemtech 27:52-57 (May 1997).
9. Dev S. Natural products in modern medicine. Arogya. J Health Sci 3:121-126 (1977).
10. Farnsworth NR. The role of medicinal plants in drug development. In: Natural Products and Drug Development (Krogsgaard-Larsen P, Christensen SB, Kofod H, eds). Copenhagen:Munksgaard, 1984;17-28.
11. Vlietinck AJ. Biologically active substances from traditional drugs. In: Biologically Active Natural Products (Hostettmann K, Lea PJ, eds). Oxford:Clarendon Press, 1987;33-47.
12. Dev S. Ayurveda and modern drug development. Proc Indian Natl Sci Acad Part A Phys Sci 54A:12-42 (1988).
13. Sharma S, ed. Realms of Ayurveda. New Delhi:Arnold-Heinemann, 1979.
14. Charaka Samhita, Vol I-VI. Jamnagar, lndia:Shree Gulab Kunverba Ayurvedic Society, 1949.
15. Sharma SP, ed. Charaka Samhita, Vol I-IV. Varanasi, India:Chaukhambha Orientalia, 1981.
16. Majumdar RC. Medicine. In: A Concise History of Science in India (Bose DM, Sen SN, Subbarayappa BV, eds). New Delhi: Indian National Science Academy, 1971;213-273.
17. Krishnamurthy KH. Wealth of Susruta. Coimbatore, India:International Institute of Ayurveda, 1991.
18. Garde GK, ed. Sartha Vagbhatta: Ashtangahridaya. Pune, India:Aryabhushana Mudranalaya, 1954.
19. Pandey G, ed. Bhava Prakash. Varanasi, India: Chaukhambha Vidya Bhavan, 1960.
20. Dahanukar SA, Thatte UM. Ayurveda Revisited. Mumbai, India:Popular Prakashan, 1989.
21. Ray P, Gupta HN, eds. Charaka Samahita. New Delhi:National Institute of Sciences of India, 1965.
22. Subbarayappa BV. India's contribution to the history of science. In: India's Contribution to World Thought and Culture (Chandra L, ed). Madras, India:Vivekananda Rock Memorial Committee, 1970:47-66.
23. Filliozat J. The expansion of Indian medicine abroad. In: India's Contribution to World Thought and Culture (Chandra L, ed). Madras, India:Vivekananda Rock Memorial Committee, 1970:67-70.
24. Hartzell JF, Zysk KG, Health, science, and the spirit: Veda and Ayurveda in the Western world. J Alternative Complementary Med 1:297-301 (1995).
25. Chatterjee A, Pakrashi SC, eds. The Treatise on Indian Medicinal Plants, Vol 1. New Delhi:Publication and Information Directorate, 1991.
26. Chopre RN. Indigenous Drugs of India. Calcutta:The Art Press, 1933.
27. Chopra RN, Chopra IC, Handa KL, Kapur LD. Chopra's Indigenous Drugs of India. Calcutta:U.S. Dhur, 1958.
28. Satyavati GV, Raina MK, Sharma M, eds. Medicinal Plants of India, Vol 1. New Delhi:Indian Council of Medical Research, 1976.
29. Satyavati GV, Gupta AK, Tandon N, eds. Medicinal Plants of India, Vol 2. New Delhi:Indian Council of Medical Research, 1987.
30. Aswal BS, Bhakuni DS, Goal AK, Kar K, Mehrotra BN. Screening of Indian plants for biological activity, Part XI. Indian J Exp Biol 22:487-504 (1984).
31. Desai HK, Gawad DH, Govindachari TR, Joshi BS, Kamat VN, Modi JD, Parthasarathy PC, Radhakrishnan J, Shanbag MN, Sighaye AR, et al. Chemical invesigation of Indian plants, Part VII. Indian J Chem 11:840-842 (1973).
32. Rastogi RP, Dhawan BN. Research on medicinal plants at the Central Drug Research Institute, Lucknow (India). Indian J Med Res 76 (suppl):27-45 (1982).
33. Chatterjee A, Pakrashi SC, eds. The Treatise on Indian Medicinal Plants, Vol 1-4. New Delhi:Publication and Information Directorate, 1991-1995.
34. Rastogi RP, Mehrotra BN, eds. Compendium of Indian Medicinal Plants, Vol 1-4. New Delhi:Publication and Information Directorate, 1990-1995.
35. Atal CK. Chemistry and Pharmacology of Vasicine - A new Oxytocic and Abortifacient. Jammu, India:Regional Research Laboratory, 1980.
36. Sharma PV. Dravyaguna Vijnan, Vol 2. Varanasi, India: Chaukhamha Bharati Academy, 1986.
37. Vazquez B, Avila G, Segura D, Escalante B. Antiinflammatory activity of extracts from aloe vera gel. J Ethnopharmacol 55:69-75 (1996).
38. Shelton RM. Aloe vera. Its chemical end therapeutic properties. Int J Dermatol 30:679-683 (1991).
39. Visen PK, Shukla B, Patnaik GK, Dhawan BN. Andrographolide protects rat hepatocytes against paracetamol-induced damage. J Ethnopharmacol 40:131-136 (1993).
40. Kapil A, Koul IB, Banerjee SK, Gupta BD. Antihepatotoxic effects of major diterpenoid constituents of Andrographis paniculata. Biochem Pharmacol 46:182-185 (1993).
41. Ravikumar PR, Soman R, Chetty GL, Pandey RC, Dev S. Chemistry of Ayurvedic crude drugs, Part VI-Shatavari-1: structure of shatavarin-IV. Indian J Chem 25B:1012-1017 (1987).
42. Joshi J, Dev S. Chemistry of Ayurvedic crude drugs. Part VIII-Shatavari-2: structure elucidation of bioactive shatavarin-I and other glycosides. Indian J Chem 27B:12-16 (1988).
43. Sharma S, Ramji S, Kumari S, Bapna JS. Randomized controlled trial of Asparagus racamosus (Shatavari) as a lactogogue in lactational inadequacy. Indian Pediatr 33:675-677 (1996).
44. Garg DS, Agarwal JP, Garg DD, eds. Neem. Dhanvantri 41:125-160 (1967).
45. Khalid SA, Duddeck H, Ganzalez-Sierra M. Isolation and characterization of an antimalarial agent of the neem tree Azadirachta indica. J Net Prod 52:922-926 (1989).
46. Singh HK, Rastogi RP, Srimal RC, Dhawan BN. Effect of bacosides A and B on avoidance responses in rats. Phytotherapy Res 2:70-75 (1988).
47. Pachnanda VK, Singh DS, Singh BS, Gupta OP, Atal CK. Clinical evaluation of Salai guggul in patients of arthritis. Indian J Pharmacol 13:63 (1981).
48. Ammon HP, Safayhi H, Mack T, Sabieraj J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 38:113-119 (1993).
49. Chandra JS, Sabir M. Modified method for isolation of palasonin - the anthelmintic principle of Butea frondosa seeds. Indian J Pharm Sci 40:97-98 (1978).
50. Kar K, Puri VN, Patnaik GK, Sur RN, Dhawan BN, Kulshrestha DK, Rastogi RP. Spasmolytic constituents of Cedrus deodara (Roxb.) Loud: pharmacological evaluation of himachalol. J Pharm Sci 64:258-262 (1975).
51. Chowdhry L, Khan ZK, Kulshrestha DK. Comparative in vitro and in vivo evaluation of himachalol in murine invasive aspergillosis. Indian J Exp Biol 35:727-734 (1997).
52. Hausen BM. Cantella asiatica (Indian pennywort), an effective therapeutic but a weak sensitizer. Contact Dermatitis 29:175-179 (1993).
53. Satyavati GV, Dwarakanath C, Tripathi SN. Experimental studies on the hypocholesterolemic effect of Commiphora mukul. Engl. (Guggul). Indian J Med Res 57:1950-1962 (1969).
54. Patil VD, Neyak UR, Dev S. Chemistry of Ayurvedic cruda drugs-I Guggulu (resin from Commiphora mukul)-1: steroidal constituents. Tetrahedron 28:2341-2352 (1972).
55. Nityanand S, Kapoor NK. Cholesterol lowering activity of the various fractions of Commiphora mukul (Guggul). Indian J Exp Biol 11:395-396 (1973).
56. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med 57:1-7 (1991).
57. Thyagarajan SP, Thiruneelakantan K, Subramanian S, Sundaravelu T. In vitro inactivation of HBsAg by Eclipta alba Hassk and Phyllanthus niruri Linn. Indian J Med Res 76(suppl):124-130 (1982).
58. Venkateswaran PS, Millman I, Blumberg BS. Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. Proc Natl Acad Sci USA 84:274-278 (1987).
59. Singh B, Rastogi RP. Chemical examination of Picrorhiza kurrooa Benth., Part VI. Reinvestigation of kutkin. Indian J Chem 10:29-31 (1972).
60. Pandey VN, Chaturvedi GN. Effect of an indigenous drug kutaki (Picrorhiza kurroa) on bile producing a biliary fistula in dogs. J Res Indian Med 5:11-26 (1970).
61. Kloss P, Schwabe W. Liver-protecting and choleretic picroside II from Picrorrhiza kurroa. Patent No. 2,203,884. Ger Offen, 1973.
62. Ansari RA, Aswal BS, Chander R, Dhawan BN, Garg NK, Kapoor NK, Kulshreshtha DK, Mehdi H, Mehrotra BN, Patnaik GK, et al. Hepatoprotective action of kutkin - the iridoid glycoside mixture of Picrorhiza kurroa. Indian J Med Res 87:401-404 (1988).
63. Mukerji B. India's wonder drug plant: Rauwolfia serpentina, birth of a new drug from an old Indian medicinal plant. In: Medal Lectures, Vol II. New Delhi:Indian National Science Academy, 1984:973-982.
64. Woodson RE, Youngken HW, Schlitter E, Schneider JA. Rauwolfia: Botany, Pharmacognosy, Chemistry and Pharmacology. Boston, MA:Little Brown & Co, 1957.
65. Sharma PV. Dravyaguna Vijnan, Vol 2. Varanasi, India:Chaukhamha Bharati Academy, 1986:691-693.
66. Mukherjee S, Sur A, Maiti BR. Hapatoprotective effect of Swertia chirata on rat. Indian J Exp Biol 35:384-388 (1997).
67. Sharma PV. Dravyaguna Vijnan, Vol 2. Varanasi, India:Chaukhamha Bharati Academy, 1986:175-178
68. Jois HS, Manjunath BL, Venkatarao S. Chemical examination of the seeds of Psoralee corylifolia. J Indian Chem Soc 10:41-46 (1933).
69. Spath E, Manjunath BL, Pailer M, Jois HS. Synthese und Konstitution des Psoralens. Chem Ber 69:1087-1090 (1936).
70. Anderson TF, Voorhaes JJ. Psoralen photochemotherapy of cutaneous disorders. Annu Rev Pharmacol Toxicol 22:235-257 (1980).
71. Mehta G, Naik UR, Dev S. Meroterpenoids. I. Psoralea corylifolia Linn. 1. Bakuchiol, a novel monoterpene phenol. Tetrahedron 29:1119-1125 (1973).
72. Prakasarao ASC, Bhalla VK, Nayak UR, Dev S. Meroterpenoids. II. Psoralee corylifolia Linn. 2. Absolute configuration of (+) - bakuchiol. Tetrahedron 29:1127-1130 (1973).
73. Damodaran NP, Dev S. Meroterpenoids. III. Psoralea corylifolia. Linn. 3. Synthesis of (±) - bakuchiol methyl ether. Tetrahedron 29:1209-1213 (1973).
74. 3, 2-hydroxybakuchiol. J Indian Chem Soc 74:970-973 (1997).
75. Noronha RV. Personal communication.
76. Sun NJ, Woo SH, Cassady JM, Snapka RM. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J Nat Prod 61:362-366 (1998).
77. Garg DS, Agarwal JP, Garg DD, eds. Shatawar. Dhanvantri 45:208-220 (1971).
78. Gaitunde BB, Jetmalani MH. Antioxytocic action of saponin isolated from Asparagus racamosus Willd (Shatavari) on uterine muscle. Arch Int Pharmacodyn Ther 179:121-129 (1969).
79. Sharma PV. Dravyaguna Vijnan, Vol 2. Varanasi, India:Chaukhamha Bharati Academy, 1986;75-78.
80. Gupta PK, Saksena SK, Dutt B, Mahadevan V. Studies on the curative effect of Cedres deodar oil against sarcoptic mange in buffalo calves. Indian J Vet Sci 38:203-209 (1968).
81. Joseph TC, Dev S. Studies in sesquiterpenes. XXIX. Structure of himechalenes. Tetrahedron 24:3809-3827 (1968).
82. Krishnappa S, Dev S. Studies in sesquiterpenes. LVIII. Deodardione, a sesquiterpene diosphenol and limonenecarboxylic acid, a possible norsesquiterpene-compounds from the wood of Cedrus deodar Loud. Tetrahedron 34:599-602 (1978).
83. Bhan P, Dev S, Bass LS, Tagle B, Clardy J. The stereochemistry of himachalol. J Chem Res (S):344-345 (1982).
84. TTK Pharma, Madras, India.
85. Shastry VVS. History of gugglu, based on Ayurvedic literature. Bull Indian Inst History Med 6:102-116 (1976).
86. Santhakumari G, Gujral ML, Sareen K. Further studies on the anti-arthritic and antiinflammatory activities of gum guggul [letter]. Indian J Physiol Pharmacol 8:36 (1964).
87. Tripathy SN, Shastri VVS, Satyavati GV. Experimental and clinical studies on the effect of guggulu (Commiphora mukul) in hyperlipemia and thrombosis. J Res Indian Med 2:10 (1968).
88. Mehta VL, Malhotra CL, Kalrah NS. Effect of various fractions of gum guggul on experimentally produced hyper-cholesterolemia in chicks. Indian J Physiol Pharmacol 12:91-95 (1968).
89. Khanna DS, Agarwal OP, Gupta SK, Arora RB. A biochemical approach to anti-atherosclerotic action of Commiphora mukul. an Indian indigenous drug in Indian domestic pigs (Sus scrofa). Indian J Med Res 57:900-906 (1969).
90. Satyavati GV. Guggulipid: a promising hypolipidaemic agent from gum guggul (Commiphora mukul). In: Economic and Medicinal Plant Research, Vol 5. Plants and Traditional Medicine (Wagner H, Farnsworth NR, eds). New York:Academic Press, 1991:47-82.
91. Patil VD, Nayak UR, Dev S. Chemistry of Ayurvedic crude drugs. II. Guggulu (resin from Commiphora mukul) - 2. Diterpenoid constituents. Tetrahedron 29:341-348 (1973).
92. Patil VD, Nayak UR, Dev S. Chemistry of Ayurvedic crude drugs. III. Guggulu (resin from Commiphora mukul) - 3. Long-chain aliphatic tetrols, a new class of naturally occurring lipids. Tetrahedron 29:1595-1598 (1973).
93. Prasad RS, Dev S. Chemistry of Ayurvedic crude drugs. IV. Guggulu (resin from Commiphora muku). 4. Absolute stereochemistry of mukulol. Tetrahedron 32:1437-1441 (1976).
94. Bajaj AG, Dev S. Chemistry of Ayurvedic crude drugs. V. Guggulu (resin from Commiphora mukul) - 5. Some new steroidal components and stereochemistry of guggulsterol-l at C-20 and C-22.Tetrahedron 38:2949-2954 (1982).
95. Kumar V, Dev S. Chemistry of Ayurvedic crude drugs. VII. Guggulu (resin from Commiphora mukul) - 6. Absolute stereochemistry of guggultetrols. Tetrahedron 43:2949-2954 (1982).
96. Dev S. Guggultetrols: a new class of naturally occurring lipids. Pure Appl Chem 61:353-356 (1989).
97. Shah CC. Studies in isolation of some useful phytochemicals [Ph D Thesis]. Baroda, India Maharaja Sayajirao University of Baroda, 1990.
98. Dev S. Chemistry of Commiphora mukul and development of a hypolipaemic drug. In: Studies in Natural Product Chemistry, Vol 5 (Atta-ur-Rahman, ed). Amsterdam: Elsevier, 1989:695-719.
99. Nand N. Personal communication.
100. Nityanand S, Kapoor NK. Hypolipidaemic effect of ethyl acetate fraction of Commiphora mukul (guggul) in rats. Indian J Pharmacol 7:106 (1975).
101. Nityanand S, Kapoor NK. Effect of guggul steroids on cholesterol biosynthesis in rats [letter]. Indian J Biochem Biophys 15:77 (1978).
102. Agarwal RC, Singh SP, Sarin RK, Das SK, Sinha N, Asthana OP, Gupta PP, Nityanand S, Dhawan BN, Agarwal SS. Clinical trial of guggulipid - a new hypolipidemic agent of plant origin in primary hyperlipidemia. Indian J Med Res 84:626-634 (1986).
103. Roth BD, Sliskovic DR, Trivedi BK. Treatment of hyper-cholesterolemia. Annu Rep Med Chem 24:147-156 (1989).
104. Darnell J, Lodish H, Baltimore D. Molecular Cell Biology. New York:Scientific American Books, 1990.
105. Skinner KJ. The chemistry of learning and memory. Chem Eng News (Oct 7):24-41 (1991).
106. Mind and Brain. Sci Am 267 (special issue):48-159 (1992).
107. Fischbach GD. Mind and brain. Sci Am 267:48-57 (1992).
108. B receptors and their significance in mammalian pharmacology. Trends Pharmacol Sci 10:401-407 (1989).
109. Willetts J, Balster RL, Leander JD. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 11:423-428 (1990).
110. Johnson G. Recent advances in excitatory amino acid research. Annu Rep Med Chem 24:41-50 (1989).
111. Johnson G, Bigge CF. Recent advances in excitatory amino acid research. Annu Rep Med Chem 26:11-22 (1991).
112. Winkler J, Suhr ST, Gage FH, Thal LJ, Fisher LJ. Essential role of naocortical acetylcholine in spatial memory. Nature 375:484-487 (1995).
113. Hershenson FM, Moos WH. Drug development for senile cognitive decline. J Med Chem 29:1125-1130 (1986).
114. Hershenson FM, Marriott JG, Moos WH. Cognitive disorders. Annu Rep Med Chem 21:31-40 (1986).
115. Mattson RJ, Moon SL. Cognitive disorders. Annu Rep Med Chem 21:29-38 (1988).
116. Pavia MR, Davis RE, Shwarz RD. Cognitive enhancers. Annu Rep Med Chem 25:21-29 (1990).
117. Selkoe DJ. Aging brain, aging mind. Sci Am 267:135-142 (1992).
118. Miranda RC, Sohrabji F. Gonadal steroid receptors: possible roles in the etiology and therapy of cognitive and neurological disorders. Annu Rep Med Chem 31:11-20 (1996).
119. Flood JF, Morley JE, Roberts E. Memory enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci USA 89:1567-1571 (1992).
120. Brennan M. Double whammy for Alzheimer's. Chem Eng News (30 September):8 (1996).
121. Brennan MB. Bringing back the memories. Chem Eng News (20 Jan):29-35 (1997).
122. Emson PC, Sandberg BEB. Cholecystokinin and substance P in the central nervous system. Annu Rep Med Chem 18:31-39 (1983).
123. Jensen RT, Wank SA, Rowley WH, Sato S, Gardner JD. Interaction of CCK with pancreatic acinar cells. Trends Pharmacol Sci 10:418-423 (1989).
124. Nadzan AM, Kerwin JF. Cholecystokinin agonists and antagonists. Annu Rep Med Chem 26:191-200 (1991).
125. Willson TM, Henke BR, Momtahen TM, Myers PL, Sugg EE, Unwalla RJ, Croom DK, Dougherty RW, Grizzle MK, Johnson MF, et al. 3-[2-(N-Phenylacetamide)]-1,5-benzo-diazepines: orally active, binding selective CCK-A agonists. J Med Chem 39:3030-3034 (1996).
126. Misra R, Cott J, Silverton J, Bhatt B, Dev S. Receptor binding studies on Ayurvedic crude drugs. II. Terminalia bellirica Roxb. Presented at 35th Annual Meeting of the American Society of Pharmacognosy, Halifax, 1994.
127. Mitchell MA, Wilks JW. Inhibitors of angiogenesis. Annu Rep Med Chem 27:139-148 (1992).